All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

Corner office podcast: Pfizer patent chief on vaccine IP and the waiver

4054a3b0-c086-469f-b541-4458ebc7bce4bryan-zielinski-chief-patent-counsel-at-pfizer-web-version-4x.jpg

In Managing IP’s first corner office podcast, Bryan Zielinski talks about his company’s IP challenges and opportunities, AI, and more

In an exclusive Managing IP podcast, Pfizer chief patent counsel Bryan Zielinski talks about his company’s patent operations and delves into the proposed COVID intellectual property waiver being discussed at the World Trade Organization.

He also discusses the important technologies that his company is working on and how his teams ensure they get sufficient patent protection, and even talks about the role artificial intelligence might play in future therapeutic discovery.

This is the first in a new podcast series brought to you by Managing IP. Click below to listen. 

 


 

More from across our site

The UPC held a pilot training system for its new IT system in London last Thursday, June 30, and a full programme will follow later this year
In-house sources say clarity on what counts as lawful access to data will be key to the success of the UK’s new copyright exception
The attitude of ISPs continues to shift following a copyright claim filed at the England and Wales High Court
The EU is seeking to create a single market for data and trade secrets owners will need to prepare early, according to IP lawyers at Osborne Clarke
In-house and private practice counsel discuss issues with pre-grant opposition in India, including the rise of non-speaking orders and straw man filings
The US Supreme Court rejected an appeal on American Axle, dashing hopes of a judicial fix to patent eligibility uncertainty
The Copyright Office refused to grant protection on the basis that the authorship couldn’t be distinguished from the final work produced by the program
COVID vaccines top Clarivate’s new brands list; Fed Circuit reverses Coca-Cola’s TTAB win; Skechers sues Brooks; USPTO to retire Public PAIR tool; CCB sees cricket complaint
Lawyers should pay attention to APJs’ questions and remember that PTAB proceedings aren’t jury trials, say former PTAB judges
The USPTO cancelled ‘Galavava’ and 'Surfstar Wake' and partly cancelled ‘Heika’ this month
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree